Assessment of Adipocyte Function in Women with PCOS
多囊卵巢综合症女性脂肪细胞功能的评估
基本信息
- 批准号:7334641
- 负责人:
- 金额:$ 18.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-01 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:11pAddressAdenovirusesAdipocytesAdipose tissueAffectAgeAgonistAmericanAndrogensBeta CellBiological AssayBiopsyBlood specimenBody mass indexBranched-Chain Amino AcidsBreathingCardiovascular DiseasesCollaborationsComplementComplexConditionConsumptionContinuous Positive Airway PressureCortisoneDataDevelopmentDiseaseDyslipidemiasElevationEnergy MetabolismEnzymesEstrogensEventExcisionFamilyFatty acid glycerol estersFeeding behaviorsGenderGlucocorticoid ReceptorGlucocorticoidsGlucoseGlucose IntoleranceGonadal Steroid HormonesHealthHepaticHeritabilityHormonalHormonesHumanHydrocortisoneHypertensionImmunoblottingImpairmentIn VitroIncidenceInsulinInsulin ResistanceInterventionKineticsLaboratoriesLeptinLeuprolideLipidsLipolysisLiverLocalizedLuciferasesMeasuresMediationMetabolicMetabolic PathwayMetabolic syndromeMetabolismMethodologyMolecularMuscleMutationNonesterified Fatty AcidsNumbersObesityObstructive Sleep ApneaOutcomeOvarianOvarian AblationPancreasPathogenesisPathologicPathologyPatientsPersonal SatisfactionPharmaceutical PreparationsPhysiologicalPlasmaPlayPolycystic Ovary SyndromePrincipal InvestigatorProductionProgesteroneProtein OverexpressionProtocols documentationREM SleepRandomizedRegulationReporterReportingResearch DesignResearch PersonnelResponse ElementsRisk FactorsRoleSatiationSex CharacteristicsSignal TransductionSkeletal MuscleSleepSleep Apnea SyndromesSlow-Wave SleepTestingTherapeutic InterventionTimeTissuesTriglyceride MetabolismTriglyceridesUniversitiesUrineWeekWeightWomanWorkacylcarnitineadenoviral-mediatedadiponectinbaseblood glucose regulationcardiovascular risk factordaydesignearly onsetgenetic manipulationglucose metabolismimprovedin vitro Assayin vivoinsightinsulin secretioninsulin sensitivityinsulin signalinginsulin tolerancelipid biosynthesislipid metabolismmenmetabolomicsnon rapid eye movementnovelprogramsreproductiveresearch studyresistinsmall hairpin RNAtoolxenoestrogen
项目摘要
Polycystic ovary syndrome (PCOS) affects up to 10% of women of reproductive age, and is characterized by
elevation in circulating androgen levels, insulin resistance, dyslipidemia and obesity. However, the
molecular mechanisms that underlie the development of the metabolic syndrome in PCOS remain unclear.
The interplay between PCOS and obstructive sleep apnea (OSA) in women may play a critical but under
appreciated role in these pathologies. Despite the recent linkage between OSA and insulin resistance, and
the finding that obese women with PCOS are up to 30 times more likely to develop OSA as weight matched
women without PCOS, most of the studies on OSA and metabolism have been conducted in men. The
central hypothesis of this application is that OSA is a novel risk factor for the development of insulin
resistance in adipose tissue in women with PCOS. We will test this hypothesis by measuring insulin
sensitivity in primary adipocytes from obese PCOS women with OSA, before and after therapeutic
intervention for the OSA. Insulin signal transduction and regulation of lipid metabolism will be assayed in
vitro and compared to values obtained in vivo. Additionally, we will determine the role alterations in
circulating glucocorticoids and the localized activation of glucocorticoids in adipocytes by the enzyme 110-
HSD1 on adipocytic insulin action. Finally, the effects of modulating reducing endogenous ovarian androgen
production on insulin signaling in adipocytes from obese PCOS women with OSA will be determined, as will
the effects of giving exogenous estrogen or progesterone to patients. Together, these studies will comprise
an integral part of a larger SCOR application that will undertake a comprehensive examination of the role of
OSA and circulating androgen on the development on insulin resistance, obesity and the metabolic
syndrome in women with PCOS.
Relevance: Women with PCOS suffer from obesity, metabolic syndrome, dysregulation of sex steroid
synthesis and obstructive sleep apnea. However, the inter connections between these various disorders is
not well understood. As part of an integrative collaborative project, this application will directly investigate
the effects of OSA and androgens on insulin sensitivity in adipocyte biopsies from PCOS patients before and
after therapeutic interventions.
多囊卵巢综合征(PCOS)影响多达10%的生殖年龄妇女,其特征是
循环雄激素水平,胰岛素抵抗,血脂异常和肥胖的升高。但是,
PCOS代谢综合征发展的基础的分子机制尚不清楚。
PCOS与女性阻塞性睡眠呼吸暂停(OSA)之间的相互作用可能会扮演关键,但在下面
在这些病理学中欣赏的作用。尽管OSA和胰岛素抵抗之间有着最近的联系,并且
随着体重匹配,患有PCOS的肥胖女性的肥胖女性的可能性高30倍
没有PCOS的女性,大多数关于OSA和代谢的研究都是在男性中进行的。这
该应用的中心假设是OSA是开发胰岛素的新风险因素
PCOS女性脂肪组织的抗性。我们将通过测量胰岛素来检验该假设
治疗前后的肥胖PCOS妇女的原发性脂肪细胞的敏感性
OSA的干预。胰岛素信号转导和脂质代谢的调节将在
体外并与体内获得的值进行比较。此外,我们将确定角色改变
通过酶110-循环糖皮质激素和脂肪细胞中糖皮质激素的局部激活
脂肪细胞胰岛素作用的HSD1。最后,调节还原内源性卵巢雄激素的影响
将确定来自患有OSA肥胖PCOS女性的脂肪细胞中胰岛素信号传导的生产,将确定
给患者提供外源雌激素或孕激素的影响。这些研究一起将包括
较大的SCOR应用程序的组成部分,该应用将对
OSA和循环雄激素在胰岛素抵抗,肥胖和代谢方面的发育中
PCOS女性的综合征。
相关性:患有PCOS的女性患有肥胖症,代谢综合征,性类固醇失调
合成和阻塞性睡眠呼吸暂停。但是,这些各种疾病之间的相互联系是
不太了解。作为综合协作项目的一部分,该应用程序将直接调查
OSA和雄激素对PCOS患者的脂肪细胞活检中胰岛素敏感性的影响
治疗干预后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A EHRMANN其他文献
DAVID A EHRMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A EHRMANN', 18)}}的其他基金
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
通过药物和睡眠呼吸暂停治疗增强 β 细胞功能
- 批准号:
8864376 - 财政年份:2011
- 资助金额:
$ 18.84万 - 项目类别:
Sex steroids, Sleep, Body Fat, and Plasma Triglycerides in Women
女性的性类固醇、睡眠、体脂肪和血浆甘油三酯
- 批准号:
8326136 - 财政年份:2011
- 资助金额:
$ 18.84万 - 项目类别:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
通过药物和睡眠呼吸暂停治疗增强 β 细胞功能
- 批准号:
8247929 - 财政年份:2011
- 资助金额:
$ 18.84万 - 项目类别:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
通过药物和睡眠呼吸暂停治疗增强 β 细胞功能
- 批准号:
8698745 - 财政年份:2011
- 资助金额:
$ 18.84万 - 项目类别:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
通过药物和睡眠呼吸暂停治疗增强 β 细胞功能
- 批准号:
8669442 - 财政年份:2011
- 资助金额:
$ 18.84万 - 项目类别:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
通过药物和睡眠呼吸暂停治疗增强 β 细胞功能
- 批准号:
8535748 - 财政年份:2011
- 资助金额:
$ 18.84万 - 项目类别:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
通过药物和睡眠呼吸暂停治疗增强 β 细胞功能
- 批准号:
8335414 - 财政年份:2011
- 资助金额:
$ 18.84万 - 项目类别:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
通过药物和睡眠呼吸暂停治疗增强 β 细胞功能
- 批准号:
8530646 - 财政年份:2011
- 资助金额:
$ 18.84万 - 项目类别:
Sex steroids, Sleep, and Metabolic Dysfunction in Women
女性的性类固醇、睡眠和代谢功能障碍
- 批准号:
7678045 - 财政年份:2007
- 资助金额:
$ 18.84万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel, Targeted Method for Bacteriophage Purification
噬菌体纯化的新型靶向方法
- 批准号:
10698983 - 财政年份:2023
- 资助金额:
$ 18.84万 - 项目类别:
Advancing Systematic Delivery of Oncolytic Adenovirus for Pancreatic Cancer
推进溶瘤腺病毒治疗胰腺癌的系统递送
- 批准号:
10734709 - 财政年份:2023
- 资助金额:
$ 18.84万 - 项目类别:
Molecular mechanisms mediating the soft tissue attachment to teeth
介导软组织附着到牙齿的分子机制
- 批准号:
10838302 - 财政年份:2023
- 资助金额:
$ 18.84万 - 项目类别:
Pulmonary endothelium targeted adenoviral gene therapy for the correction of mucopolysaccharidosis type I
肺内皮靶向腺病毒基因治疗纠正 I 型粘多糖贮积症
- 批准号:
10678053 - 财政年份:2023
- 资助金额:
$ 18.84万 - 项目类别: